Related Experiment Video
Updated: Aug 1, 2026
Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice
Published on: October 3, 2011
Abolishing Trp53-dependent apoptosis does not benefit spinal muscular atrophy model mice
Ming Shiun Tsai1, Yung Tsung Chiu, Sue Hong Wang
1Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
Abstract:
Spinal muscular atrophy (SMA) is the most common genetic motoneuron degenerative disorder, but the mechanism(s) of motoneuron death is unclear. Previously, a direct interaction between tumor-suppressive TP53 protein and the SMA determinant gene product, survival motor neuron protein, was identified and therefore it has been suggested that a mechanism of TP53-dependent apoptosis plays an important role in motoneuron degeneration in SMA. We used our SMA model mice, generated by a combination of knockout and transgenic techniques, to decipher the role of TP53 protein in the motoneuron degeneration in SMA. We detected a significant increase of Trp53 expression in the spinal cord of SMA-like mice compared to their normal littermates. After crossing SMA-like mice with Trp53 knockout mice, the progeny Trp53-deficient SMA-like mice did not show milder disease severity or longer lifespan compared to SMA littermates with wild-type Trp53 genes. Our studies provide in vivo evidence indicating that Trp53-dependent apoptosis does not play a crucial role in motoneuron degeneration in SMA-like mice. European Journal of Human Genetics (2006) 14, 372-375. doi:10.1038/sj.ejhg.5201556; published online 4 January 2006.
Insights
TP53-dependent apoptosis does not drive motoneuron death in spinal muscular atrophy (SMA). Studies in SMA model mice show that removing the Trp53 gene does not alter disease severity or lifespan, refuting a key hypothesis.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Spinal muscular atrophy (SMA) is a common genetic disorder affecting motor neurons.
- The precise mechanisms of motor neuron degeneration in SMA remain unclear.
- Previous research suggested a role for TP53-dependent apoptosis due to interactions with survival motor neuron protein.
Purpose of the Study:
- To investigate the role of TP53 protein in motor neuron degeneration in a mouse model of SMA.
- To determine if TP53-dependent apoptosis contributes to the disease pathology in SMA.
Main Methods:
- Generation of SMA model mice using knockout and transgenic techniques.
- Analysis of Trp53 gene expression in the spinal cord of SMA-like mice.
- Crossbreeding SMA-like mice with Trp53 knockout mice to create Trp53-deficient SMA-like mice.
Main Results:
- Trp53 expression was significantly increased in the spinal cord of SMA-like mice.
- Trp53-deficient SMA-like mice exhibited no improvement in disease severity or lifespan compared to controls.
- These findings indicate that Trp53-dependent apoptosis is not a major factor in SMA motor neuron degeneration.
Conclusions:
- TP53-dependent apoptosis does not play a critical role in the motor neuron degeneration observed in this SMA mouse model.
- The study provides in vivo evidence against a previously proposed mechanism of SMA pathogenesis.
More Related Videos
06:12Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis
Published on: January 11, 2014
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
